Suppr超能文献

β3 激动剂 CL-316,243 诱导的白色脂肪组织“类棕色”表型的持续时间

Duration of a "Brown-Like" Phenotype of White Adipose Tissue Induced by the β3 Agonist CL-316,243.

作者信息

Danysz Wojciech, Jinlai Kang, Li Fugang

机构信息

Merz Pharmaceuticals, Frankfurt, Germany.

HD Biosciences Ltd, Shanghai, China.

出版信息

Drug Res (Stuttg). 2019 May;69(5):265-270. doi: 10.1055/a-0667-8744. Epub 2018 Sep 6.

Abstract

"Browning" i. e. the transformation of white adipose tissue into brown-like adipose tissue could induce efficient burning of excess fat reserves via induction of non-shivering thermogenesis. For example, activation of ß3 adrenergic receptors has been show to induce such changes, however, it is still not clear, how long after termination of such a treatment, beneficial effects might be maintained. To address this question, we treated rats s.c. for 2 weeks with the ß3 agonist CL-316,243 at 1 mg/kg and assessed interscapular brown fat and inguinal white fat pads weight, UCP-1 (a marker for the brown-like fat phenotype) using immunohistochemistry and H&E staining, at different intervals after treatment termination.One 1 day after the treatment cessation there was a decrease of inguinal white fat pad weight and increase of interscapular fat pad. This change vanished at 7 days for inguinal pad and at 14 days for interscapular pad. Histological analysis of interscapular pads showed increased UCP-1 staining and brown-like morphology in H&E staining slices at 1 day, but not other time points. In case of inguinal pad there were brown-like features in H&E slices at 1 day and less after 7 days, but absent at 14 days. UCP-1 staining was only detected 1 day after the treatment.In conclusion, the present results indicate that browning-like changes of white fat may be short lasting after treatment termination and could require maintenance treatment of inductor to achieve desired therapeutic effect. This might be a serious shortcoming of potential therapeutic use.

摘要

“褐变”,即白色脂肪组织转变为褐色脂肪样组织,可通过诱导非颤抖性产热来有效燃烧多余的脂肪储备。例如,已表明激活β3肾上腺素能受体会诱导此类变化,然而,尚不清楚在这种治疗终止后,有益效果能维持多长时间。为解决这个问题,我们以1毫克/千克的剂量给大鼠皮下注射β3激动剂CL - 316,243,持续2周,并在治疗终止后的不同时间间隔,评估肩胛间褐色脂肪和腹股沟白色脂肪垫的重量,使用免疫组织化学和苏木精 - 伊红染色法检测UCP - 1(褐色脂肪样表型的标志物)。治疗停止1天后,腹股沟白色脂肪垫重量减少,肩胛间脂肪垫重量增加。这种变化在腹股沟脂肪垫7天时消失,在肩胛间脂肪垫14天时消失。肩胛间脂肪垫的组织学分析显示,在第1天,苏木精 - 伊红染色切片中UCP - 1染色增加且呈现褐色脂肪样形态,但在其他时间点未出现。对于腹股沟脂肪垫,在第1天的苏木精 - 伊红切片中有褐色脂肪样特征,7天后减少,14天时消失。仅在治疗后1天检测到UCP - 1染色。总之,目前的结果表明,白色脂肪的褐变样变化在治疗终止后可能持续时间较短,可能需要诱导剂的维持治疗才能达到预期的治疗效果。这可能是潜在治疗应用的一个严重缺点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验